| 2019 | Efficacy and Safety of Besifovir Dipivoxil Maleate Compared With Tenofovir Disoproxil Fumarate in Treatment of Chronic Hepatitis B Virus Infection
| CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
| 2019 | Efficacy and safety of biosimilar CT-P13 compared with originator infliximab in patients with active Crohn's disease: an international, randomised, double-blind, phase 3 non-inferiority study | LANCET |
| 2013 | Efficacy and safety of biphasic insulin aspart 30/70 in type 2 diabetes suboptimally controlled on oral antidiabetic therapy in Korea: a multicenter, open-label, single-arm study (diabetes metab j 2013;37:117-24).
| DIABETES & METABOLISM JOURNAL |
| 2022 | Efficacy and Safety of Botulinum Toxin Type A (NABOTA) for Post-stroke Upper Extremity Spasticity: A Multicenter Phase IV Trial
| Annals of Rehabilitation Medicine |
| 2022 | Efficacy and Safety of Brigatinib Compared With Crizotinib in Asian vs. Non-Asian Patients With Locally Advanced or Metastatic ALK-Inhibitor-Naive ALK+ Non-Small Cell Lung Cancer: Final Results From the Phase III ALTA-1L Study
| CLINICAL LUNG CANCER |
| 2019 | Efficacy and Safety of Ceritinib (450 mg/d or 600 mg/d) With Food Versus 750-mg/d Fasted in Patients With ALK Receptor Tyrosine Kinase (ALK)-Positive NSCLC: Primary Efficacy Results From the ASCEND-8 Study
| JOURNAL OF THORACIC ONCOLOGY |
| 2023 | Efficacy and Safety of Ceritinib 450 mg/day with Food and 750 mg/day in Fasted State in Treatment-Naïve Patients with ALK+ Non-Small Cell Lung Cancer: Results from the ASCEND-8 Asian Subgroup Analysis
| CANCER RESEARCH AND TREATMENT |
| 2011 | Efficacy and safety of combination therapy with mirodenafil and α1-blocker for benign prostatic hyperplasia-induced lower urinary tract symptoms accompanied by erectile dysfunction: a multicenter, open-label, prospective study | INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH |
| 2022 | Efficacy and Safety of CT-P10 Versus Rituximab in Untreated Low-Tumor-Burden Follicular Lymphoma: Final Results of a Randomized Phase III Study
| CLINICAL LYMPHOMA MYELOMA & LEUKEMIA |
| 2022 | Efficacy and Safety of DA-8010, a Novel M3 Antagonist, in Patients With Overactive Bladder: A Randomized, Double-Blind Phase 2 Study
| INTERNATIONAL NEUROUROLOGY JOURNAL(대한배뇨장애요실금학회지) |
| 2010 | Efficacy and safety of deferiprone (Ferriprox), an oral iron-chelating agent, in pediatric patients
| Korean Journal of Hepatology (대한간학회지) |
| 2015 | Efficacy and safety of degarelix in Korean patients with prostate cancer requiring androgen deprivation therapy: Open-label multicenter phase III study
| PROSTATE INTERNATIONAL |
| 2017 | Efficacy and Safety of Different Aceclofenac Treatments for Chronic Lower Back Pain: Prospective, Randomized, Single Center, Open-Label Clinical Trials
| YONSEI MEDICAL JOURNAL |
| 2016 | Efficacy and safety of dovitinib in pretreated patients with advanced squamous non-small cell lung cancer with FGFR1 amplification: A single-arm, phase 2 study | CANCER |
| 2016 | Efficacy and Safety of DP-R202 in Patients with Chronic Artery Occlusive Disease: Multicenter Randomized Double-blind Active-controlled Parallel Group Phase III Clinical Study.
| CLINICAL THERAPEUTICS |
| 2022 | Efficacy and safety of dronedarone versus placebo in patients with atrial fibrillation stratified according to renal function: Post hoc analyses of the EURIDIS-ADONIS trials
| CLINICAL CARDIOLOGY |
| 2016 | Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI | JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY |
| 2018 | Efficacy and safety of dual antiplatelet therapy after coronary stenting in patients with chronic kidney disease | AMERICAN HEART JOURNAL |
| 2009 | Efficacy and safety of dutasteride, tamsulosin and their combination in a subpopulation of the CombAT study: 2-year results in Asian men with moderate-to-severe BPH | PROSTATE CANCER AND PROSTATIC DISEASES |
| 2021 | Efficacy and Safety of DWJ1252 Compared With Gasmotin in the Treatment of Functional Dyspepsia: A Multicenter, Randomized, Double-blind, Active-controlled Study
| JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY |
